Most patients taking GLP-1 agonists are experiencing positive outcomes for managing type 2 diabetes and obesity. With all the ...

A heart failure polypill was not only associated with better adherence to guideline-directed medicines but also better ...

Peak nasal inspiratory flow offers a feasible, noninvasive measure of nasal airflow obstruction in children with cystic ...

The prevalence nearly doubled between 2000 and 2020, with rates among youth nearly eight times higher in those with than ...

Results of a randomized clinical trial published in the JAMA Network Open showed participants who engaged in 6 weeks of daily ...

A Royal College of Nursing survey found that many nurses are working while ill due to understaffing and increasing workloads.

The drug's recent approval and safety data in women with a history of breast cancer mean there is a new option for women not ...

The broadened approvals include pediatric formulations for rare tumor therapy and wider applications for blood cancers, ...

The EMA’s CHMP has endorsed Ondibta for diabetes and Osqay for osteoporosis, a move that could broaden access to effective, ...

The recombinant vaccine VacPertagen offers booster protection for adolescents and adults while delivering passive immunity to ...

The EMA initially rejected Rezurock due to uncertainty over its clinical benefit, noting that the pivotal study had no comparator arm and permitted concomitant therapies.

A man in his seventies developed fulminant capecitabine toxicity despite normal DPYD screening, revealing a rare variant that ...